Trial Profile
Randomized Study of Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Jan 2024
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Chronic inflammatory demyelinating polyradiculoneuropathy
- Focus Therapeutic Use
- Sponsors CSL Behring
- 26 Jul 2023 Planned End Date changed from 1 Jan 2027 to 20 Dec 2029.
- 26 Jul 2023 Planned primary completion date changed from 1 Jan 2027 to 20 Dec 2029.
- 24 Aug 2022 Planned End Date changed from 1 Jan 2023 to 1 Jan 2027.